Integra Inventory vs Non Current Assets Total Analysis

IART Stock

USD 30.80 0.31 1.00%

Integra LifeSciences financial indicator trend analysis is infinitely more than just investigating Integra LifeSciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Integra LifeSciences is a good investment. Please check the relationship between Integra LifeSciences Inventory and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Inventory vs Non Current Assets Total

Inventory vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Integra LifeSciences Inventory account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Integra LifeSciences' Inventory and Non Current Assets Total is 0.93. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Integra LifeSciences Holdings, assuming nothing else is changed. The correlation between historical values of Integra LifeSciences' Inventory and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Integra LifeSciences Holdings are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Inventory i.e., Integra LifeSciences' Inventory and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Inventory

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from Integra LifeSciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Integra LifeSciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Integra LifeSciences' Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 442.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 339.5 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	944.6M	970.3M	888.4M	458.0M
Total Revenue	1.5B	1.6B	1.5B	1.6B

Gross Profit Total Revenue

Integra LifeSciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Common Stock Total Equity	Short Term Investments	Short Term Debt
Total Assets		0.97	0.87	0.97	0.95	0.94	0.83	0.86	0.81	0.99	-0.27	0.83	0.96	0.81	0.99	0.93	0.68	0.78	0.99	0.85	0.96	0.97	0.98	0.85	0.68	0.01
Other Current Liab	0.97		0.89	0.92	0.87	0.94	0.75	0.81	0.8	0.97	-0.12	0.81	0.94	0.82	0.97	0.9	0.69	0.78	0.98	0.77	0.94	0.96	0.98	0.84	0.61	0.0
Total Current Liabilities	0.87	0.89		0.81	0.73	0.84	0.55	0.75	0.78	0.85	-0.23	0.77	0.84	0.83	0.86	0.74	0.84	0.87	0.88	0.56	0.86	0.87	0.89	0.9	0.37	0.0
Total Stockholder Equity	0.97	0.92	0.81		0.96	0.84	0.87	0.82	0.85	0.96	-0.34	0.86	0.92	0.8	0.92	0.92	0.65	0.79	0.92	0.88	0.96	0.92	0.91	0.84	0.7	0.03
Property Plant And Equipment Net	0.95	0.87	0.73	0.96		0.84	0.91	0.87	0.76	0.94	-0.27	0.79	0.91	0.73	0.91	0.95	0.53	0.66	0.9	0.93	0.92	0.87	0.88	0.76	0.76	-0.01
Net Debt	0.94	0.94	0.84	0.84	0.84		0.69	0.88	0.62	0.95	-0.11	0.64	0.95	0.76	0.98	0.88	0.62	0.7	0.98	0.71	0.84	0.96	0.98	0.8	0.57	-0.04
Retained Earnings	0.83	0.75	0.55	0.87	0.91	0.69		0.71	0.77	0.8	-0.36	0.81	0.74	0.51	0.78	0.86	0.45	0.39	0.78	0.97	0.86	0.71	0.76	0.58	0.88	-0.11
Accounts Payable	0.86	0.81	0.75	0.82	0.87	0.88	0.71		0.55	0.87	-0.31	0.57	0.93	0.68	0.86	0.85	0.43	0.63	0.86	0.74	0.78	0.85	0.86	0.72	0.48	-0.16
Cash	0.81	0.8	0.78	0.85	0.76	0.62	0.77	0.55		0.76	-0.41	1.0	0.67	0.6	0.75	0.68	0.76	0.65	0.76	0.75	0.91	0.72	0.77	0.68	0.64	0.01
Non Current Assets Total	0.99	0.97	0.85	0.96	0.94	0.95	0.8	0.87	0.76		-0.25	0.78	0.97	0.81	0.99	0.93	0.64	0.79	0.99	0.84	0.93	0.99	0.98	0.86	0.66	0.02
Non Currrent Assets Other	-0.27	-0.12	-0.23	-0.34	-0.27	-0.11	-0.36	-0.31	-0.41	-0.25		-0.4	-0.22	-0.18	-0.21	-0.14	-0.21	-0.21	-0.2	-0.35	-0.3	-0.23	-0.2	-0.24	-0.15	0.04
Cash And Short Term Investments	0.83	0.81	0.77	0.86	0.79	0.64	0.81	0.57	1.0	0.78	-0.4		0.68	0.59	0.77	0.71	0.75	0.63	0.78	0.79	0.92	0.73	0.78	0.69	0.69	0.0
Net Receivables	0.96	0.94	0.84	0.92	0.91	0.95	0.74	0.93	0.67	0.97	-0.22	0.68		0.85	0.95	0.93	0.6	0.79	0.96	0.76	0.89	0.96	0.95	0.85	0.53	0.0
Common Stock Shares Outstanding	0.81	0.82	0.83	0.8	0.73	0.76	0.51	0.68	0.6	0.81	-0.18	0.59	0.85		0.79	0.8	0.62	0.88	0.79	0.52	0.78	0.83	0.78	0.87	0.25	0.27
Non Current Liabilities Total	0.99	0.97	0.86	0.92	0.91	0.98	0.78	0.86	0.75	0.99	-0.21	0.77	0.95	0.79		0.92	0.66	0.74	1.0	0.81	0.92	0.98	1.0	0.83	0.66	0.0
Inventory	0.93	0.9	0.74	0.92	0.95	0.88	0.86	0.85	0.68	0.93	-0.14	0.71	0.93	0.8	0.92		0.54	0.64	0.92	0.85	0.91	0.88	0.9	0.75	0.67	0.0
Other Current Assets	0.68	0.69	0.84	0.65	0.53	0.62	0.45	0.43	0.76	0.64	-0.21	0.75	0.6	0.62	0.66	0.54		0.68	0.69	0.38	0.77	0.64	0.7	0.68	0.4	0.01
Other Stockholder Equity	0.78	0.78	0.87	0.79	0.66	0.7	0.39	0.63	0.65	0.79	-0.21	0.63	0.79	0.88	0.74	0.64	0.68		0.75	0.44	0.73	0.82	0.74	0.87	0.21	0.2
Total Liab	0.99	0.98	0.88	0.92	0.9	0.98	0.78	0.86	0.76	0.99	-0.2	0.78	0.96	0.79	1.0	0.92	0.69	0.75		0.8	0.93	0.98	1.0	0.84	0.65	0.0
Property Plant And Equipment Gross	0.85	0.77	0.56	0.88	0.93	0.71	0.97	0.74	0.75	0.84	-0.35	0.79	0.76	0.52	0.81	0.85	0.38	0.44	0.8		0.84	0.76	0.78	0.62	0.88	-0.08
Total Current Assets	0.96	0.94	0.86	0.96	0.92	0.84	0.86	0.78	0.91	0.93	-0.3	0.92	0.89	0.78	0.92	0.91	0.77	0.73	0.93	0.84		0.88	0.93	0.8	0.69	-0.01
Intangible Assets	0.97	0.96	0.87	0.92	0.87	0.96	0.71	0.85	0.72	0.99	-0.23	0.73	0.96	0.83	0.98	0.88	0.64	0.82	0.98	0.76	0.88		0.97	0.87	0.58	0.04
Short Long Term Debt Total	0.98	0.98	0.89	0.91	0.88	0.98	0.76	0.86	0.77	0.98	-0.2	0.78	0.95	0.78	1.0	0.9	0.7	0.74	1.0	0.78	0.93	0.97		0.83	0.63	-0.03
Common Stock Total Equity	0.85	0.84	0.9	0.84	0.76	0.8	0.58	0.72	0.68	0.86	-0.24	0.69	0.85	0.87	0.83	0.75	0.68	0.87	0.84	0.62	0.8	0.87	0.83		0.42	0.28
Short Term Investments	0.68	0.61	0.37	0.7	0.76	0.57	0.88	0.48	0.64	0.66	-0.15	0.69	0.53	0.25	0.66	0.67	0.4	0.21	0.65	0.88	0.69	0.58	0.63	0.42		-0.12
Short Term Debt	0.01	0.0	0.0	0.03	-0.01	-0.04	-0.11	-0.16	0.01	0.02	0.04	0.0	0.0	0.27	0.0	0.0	0.01	0.2	0.0	-0.08	-0.01	0.04	-0.03	0.28	-0.12

Click cells to compare fundamentals

Integra LifeSciences Account Relationship Matchups

Integra LifeSciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.3B	3.6B	3.8B	3.9B	3.8B	4.0B
Other Current Liab	156.2M	182.1M	213.1M	158.8M	176.3M	185.1M
Total Current Liabilities	331.3M	401.0M	340.0M	320.9M	307.0M	158.9M
Total Stockholder Equity	1.4B	1.5B	1.7B	1.8B	1.6B	1.7B
Property Plant And Equipment Net	431.9M	371.2M	396.2M	459.6M	496.4M	521.2M
Net Debt	1.3B	1.2B	1.1B	1.2B	1.4B	1.5B
Retained Earnings	398.6M	532.3M	698.6M	879.1M	946.9M	994.2M
Accounts Payable	113.1M	54.6M	61.8M	102.1M	92.3M	96.9M
Cash	198.9M	470.2M	513.4M	456.7M	276.4M	290.2M
Non Current Assets Total	2.4B	2.4B	2.6B	2.7B	2.7B	2.9B
Non Currrent Assets Other	11.2M	11.3M	10.0M	(510.2M)	26.0M	27.3M
Cash And Short Term Investments	198.9M	470.2M	513.4M	456.7M	309.1M	324.6M
Net Receivables	275.3M	225.5M	231.8M	263.5M	259.3M	272.3M
Common Stock Shares Outstanding	86.5M	85.2M	85.5M	83.5M	80.3M	67.2M
Liabilities And Stockholders Equity	3.3B	3.6B	3.8B	3.9B	3.8B	4.0B
Non Current Liabilities Total	1.6B	1.7B	1.8B	1.8B	1.9B	2.0B
Inventory	316.1M	310.1M	317.4M	324.6M	389.6M	409.1M
Other Current Assets	67.9M	231.4M	91.1M	116.8M	100.0M	51.5M
Other Stockholder Equity	1.1B	1.1B	1.0B	914.1M	655.2M	467.2M
Total Liab	1.9B	2.1B	2.1B	2.1B	2.2B	2.3B
Property Plant And Equipment Gross	431.9M	371.2M	711.1M	789.3M	863.8M	907.0M
Total Current Assets	858.2M	1.2B	1.2B	1.2B	1.1B	1.1B
Accumulated Other Comprehensive Income	(76.4M)	(74.1M)	(45.2M)	10.3M	(15.1M)	(15.9M)
Intangible Assets	1.0B	989.4M	1.1B	1.1B	1.1B	1.1B
Short Long Term Debt Total	1.5B	1.7B	1.7B	1.6B	1.7B	1.8B
Common Stock Total Equity	887K	893K	896K	905K	1.0M	528.7K
Short Term Investments	1.5M	4.7M	12K	16.7M	32.7M	34.3M
Short Term Debt	57.3M	159.1M	59.8M	52.7M	29.8M	28.3M
Common Stock	887K	893K	896K	905K	909K	547.5K
Other Liab	116.1M	131.2M	135.9M	201.8M	232.1M	243.7M
Other Assets	27.3M	168.6M	3.8B	63.2M	72.6M	69.0M
Long Term Debt	1.2B	1.4B	1.4B	1.3B	1.5B	749.7M
Treasury Stock	(119.9M)	(235.1M)	(234.4M)	(362.9M)	(326.6M)	(310.2M)
Property Plant Equipment	337.4M	287.5M	311.7M	311.3M	358.0M	375.9M
Current Deferred Revenue	4.8M	5.3M	5.3M	7.3M	8.5M	5.3M
Good Will	954.3M	932.4M	1.0B	1.0B	1.1B	1.1B
Net Tangible Assets	(569.1M)	(406.9M)	(474.2M)	(361.1M)	(325.0M)	(341.2M)
Retained Earnings Total Equity	398.6M	532.3M	698.6M	879.1M	1.0B	1.1B
Long Term Debt Total	1.2B	1.4B	1.4B	1.3B	1.5B	1.0B
Capital Surpluse	1.2B	1.3B	1.3B	1.3B	1.5B	1.0B

Pair Trading with Integra LifeSciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Integra LifeSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integra LifeSciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Integra Stock

0.72	DH	Definitive Healthcare	Pair Corr
0.71	FEMY	Femasys	Pair Corr

Moving against Integra Stock

0.85	HAE	Haemonetics	Pair Corr
0.71	JYNT	Joint Corp	Pair Corr
0.69	WGS	GeneDx Holdings Corp	Pair Corr
0.65	GCTK	GlucoTrack	Pair Corr
0.56	LMAT	LeMaitre Vascular	Pair Corr

The ability to find closely correlated positions to Integra LifeSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Integra LifeSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Integra LifeSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Integra LifeSciences Holdings to buy it.

The correlation of Integra LifeSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Integra LifeSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Integra LifeSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Integra LifeSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC